Article
Monoclonal Antibody Therapeutics for Infectious Diseases: Beyond Normal Human Immunoglobulin
2022-01-31
Abstract excerpt
Antibody therapy is effective for treating infectious diseases. Due to the coronavirus disease 2019 (COVID-19) pandemic and the rise of drug-resistant bacteria, rapid development of neutralizing monoclonal antibodies (mAbs) to treat infectious diseases is urgently needed. Using a therapeutic human mAb with the lowest immunogenicity is recommended, because chimera and humanized mAbs are occasionally immunogenic. In...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e7eb3de-975b-516c-a9cc-8b25eead3d09
- DOI
- 10.2139/ssrn.4022365
